{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:03:51Z","timestamp":1767909831119,"version":"3.49.0"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00125-025-06378-7","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T02:02:07Z","timestamp":1748224927000},"page":"1597-1599","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical guidelines and other guidance from the European Association for the Study of Diabetes (EASD)"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8911-6744","authenticated-orcid":false,"given":"Richard I. G.","family":"Holt","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0221-4072","authenticated-orcid":false,"given":"Apostolos","family":"Tsapas","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3703-0011","authenticated-orcid":false,"given":"Manuela","family":"Meireles","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6593-8417","authenticated-orcid":false,"given":"Hindrik","family":"Mulder","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4055-5233","authenticated-orcid":false,"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"6378_CR1","doi-asserted-by":"publisher","unstructured":"Graham R, Mancher M, Miller Wolman D, Greenfield S, Steinberg E (2011) Clinical practice guidelines we can trust. National Academies Trust, Washington DC, USA. https:\/\/doi.org\/10.17226\/13058","DOI":"10.17226\/13058"},{"issue":"7","key":"6378_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.7326\/0003-4819-156-7-201204030-00009","volume":"156","author":"A Qaseem","year":"2012","unstructured":"Qaseem A, Forland F, Macbeth F, Ollenschl\u00e4ger G, Phillips S, van der Wees P (2012) Guidelines International Network: toward international standards for clinical practice guidelines. Ann Intern Med 156(7):525\u2013531. https:\/\/doi.org\/10.7326\/0003-4819-156-7-201204030-00009","journal-title":"Ann Intern Med"},{"key":"6378_CR3","doi-asserted-by":"publisher","unstructured":"Karagiannis T, Advani A, Davies MJ et al (2025) European Association for the Study of Diabetes (EASD) Standard Operating Procedure for the development of guidelines. Diabetologia. https:\/\/doi.org\/10.1007\/s00125-025-06370-1","DOI":"10.1007\/s00125-025-06370-1"},{"key":"6378_CR4","doi-asserted-by":"publisher","unstructured":"Meireles M, Holt R, Tsapas A, Mulder H, Mathieu C (2025) The new era of European Association for the Study of Diabetes (EASD)\u00a0clinical\u00a0guidance documents. Diabetologia. https:\/\/doi.org\/10.1007\/s00125-025-06452-0","DOI":"10.1007\/s00125-025-06452-0"},{"issue":"1","key":"6378_CR5","doi-asserted-by":"publisher","first-page":"e1004326","DOI":"10.1371\/journal.pmed.1004326","volume":"21","author":"WT Gattrell","year":"2024","unstructured":"Gattrell WT, Logullo P, van Zuuren EJ et al (2024) ACCORD (ACcurate COnsensus Reporting Document): a reporting guideline for consensus methods in biomedicine developed via a modified Delphi. PLoS Med 21(1):e1004326. https:\/\/doi.org\/10.1371\/journal.pmed.1004326","journal-title":"PLoS Med"},{"key":"6378_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/J.JCLINEPI.2016.09.009","volume":"81","author":"HJ Sch\u00fcnemann","year":"2017","unstructured":"Sch\u00fcnemann HJ, Wiercioch W, Brozek J et al (2017) GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT. J Clin Epidemiol 81:101\u2013110. https:\/\/doi.org\/10.1016\/J.JCLINEPI.2016.09.009","journal-title":"J Clin Epidemiol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06378-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-025-06378-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06378-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:41:14Z","timestamp":1752154874000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-025-06378-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":6,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["6378"],"URL":"https:\/\/doi.org\/10.1007\/s00125-025-06378-7","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"26 May 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RIGH is the Chair of the EASD Committee on Clinical Affairs. RIGH has received fees for lecturing from Boehringer Ingelheim, EASD, Eli Lilly, Encore, Liberum, Novo Nordisk and ROVI, and funding for conference attendance from Novo Nordisk and Eli Lilly. AT is the Chair of the EASD Guidelines Oversight Committee. AT has received support for attending meetings and\/or economy travel from Bayer, Menarini and Novo Nordisk, outside the submitted work. MM is the EASD Chief Scientific Officer and HM is the Editor of Diabetologia. CM is the President of the EASD. CM serves or has served on the advisory panel for Novo Nordisk, Sanofi, Eli Lilly, Novartis, Boehringer Ingelheim, Roche, Medtronic, Imcyse, Insulet, Biomea Fusion and Vertex. Financial compensation for these activities has been received by KU Leuven. KU Leuven has received research support for CM from Medtronic, Imcyse, Novo Nordisk, Sanofi and ActoBio Therapeutics. CM serves or has served on the speakers\u2019 bureau for Novo Nordisk, Sanofi, Eli Lilly, Medtronic and Boehringer Ingelheim. Financial compensation for these activities has been received by KU Leuven. All external support provided to the EASD can be found at .","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"All authors contributed to the concept of the work. RIGH wrote the first draft. All authors critically reviewed the article and approved the final version for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}